GPT and chronic hepatitis B virus infection: High pretreatment ALT levels, low pretreatment HBV DNA levels, sex, age, and HBV genotype A or B are considered predictors of a good response to PEG-IFN treatment for HBeAg-positive chronic hepatitis B patients (8,17–20).